(Q39382412)

11 September 2017

Survey of cannabis use in patients with amyotrophic lateral sclerosis (English)

1 reference

amyotrophic lateral sclerosis

11 September 2017

0 references

0 references

2

Patrick Weydt

1 reference

11 September 2017

Dagmar Amtmann

1

1 reference

11 September 2017

Kurt L Johnson

series ordinal

3

1 reference

11 September 2017

Mark P Jensen

series ordinal

4

1 reference

11 September 2017

Gregory T Carter

series ordinal

5

1 reference

11 September 2017

1 March 2004

1 reference

American Journal of Hospice and Palliative Medicine

11 September 2017

1 reference

11 September 2017

21

1 reference

11 September 2017

95-104

1 reference

11 September 2017

2

1 reference

Onset, natural history and outcome in idiopathic adult motor neuron disease

11 September 2017

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

The natural history of amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

Rising amyotrophic lateral sclerosis mortality in France 1968-1990: increased life expectancy and inter-disease competition as an explanation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

Amyotrophic lateral sclerosis is a multifactorial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

Marijuana in the management of amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

Terminal elimination plasma half-life of delta 1-tetrahydrocannabinol (delta 1-THC) in heavy users of marijuana.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

Structure-activity analysis of anandamide analogs: relationship to a cannabinoid pharmacophore.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

A random walk through a cannabis field

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

The residual cognitive effects of heavy marijuana use in college students.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

Medicinal applications of delta-9-tetrahydrocannabinol and marijuana

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

The perceived effects of smoked cannabis on patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

Effects of smoked marijuana on food intake and body weight of humans living in a residential laboratory.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

Effect of cannabinoids on spasticity and ataxia in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

An analgesia circuit activated by cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

Analgesic Effect of Delta‐9‐Tetrahydrocannabinol

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

The analgesic properties of delta-9-tetrahydrocannabinol and codeine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

Expanding the role of hospice care in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

World wide web: opportunities, challenges, and threats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

Rising mortality from motoneuron disease in the USA, 1962-84.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

The use of alternative medicine by patients with amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

The ALS Patient Care Database: insights into end-of-life care in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F104990910402100206

10.1177/104990910402100206

21 January 2018

Identifiers

DOI

1 reference

11 September 2017

1 reference